Ignite Creation Date:
2025-12-25 @ 12:00 AM
Ignite Modification Date:
2026-03-03 @ 3:53 PM
Study NCT ID:
NCT01801358
Status:
TERMINATED
Last Update Posted:
2020-09-16
First Post:
2013-02-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase Ib/II Study of AEB071 and MEK162 in Adult Patients With Metastatic Uveal Melanoma
Sponsor:
Array Biopharma, now a wholly owned subsidiary of Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-08
Start Date Type:
None
Primary Completion Date:
2015-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-05
Completion Date Type:
ACTUAL
First Submit Date:
2013-02-21
First Submit QC Date:
None
Study First Post Date:
2013-02-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-05-12
Results First Submit QC Date:
None
Results First Post Date:
2016-10-20
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2016-03-11
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2020-09-14
Last Update Post Date:
2020-09-16
Last Update Post Date Type:
ACTUAL